Skip to main content
SpringerLink
Log in

Antibodies' long revenue stream spurs pharma acquisitions

  • News
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. London

    Peter Mitchell

Authors
  1. Peter Mitchell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mitchell, P. Antibodies' long revenue stream spurs pharma acquisitions. Nat Biotechnol 25, 1194–1195 (2007). https://doi.org/10.1038/nbt1107-1194

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1107-1194

  • Springer Nature America, Inc.

Search

Navigation